Nikunj V. Somia - Publications

Affiliations: 
Molecular, Cellular, Developmental Biology and Genetics University of Minnesota, Twin Cities, Minneapolis, MN 
Area:
Molecular Biology

34 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Stach C, McCann M, O'Brien C, Le TS, Somia N, Chen X, Lee K, Fu HY, Daoutidis P, Zhao L, Hu WS, Smanski MJ. Model-driven engineering of N-linked glycosylation in Chinese Hamster Ovary cells. Acs Synthetic Biology. PMID 31596566 DOI: 10.1021/Acssynbio.9B00215  0.376
2018 O'Brien SA, Lee K, Fu HY, Lee Z, Le TS, Stach CS, McCann MG, Zhang AQ, Smanski MJ, Somia NV, Hu WS. Single Copy Transgene Integration in a Transcriptionally Active Site for Recombinant Protein Synthesis. Biotechnology Journal. e1800226. PMID 30024101 DOI: 10.1002/Biot.201800226  0.438
2016 Podetz-Pedersen KM, Olson ER, Somia NV, Russell SJ, McIvor RS. A Broad Range of Dose Optima Achieve High-level, Long-term Gene Expression After Hydrodynamic Delivery of Sleeping Beauty Transposons Using Hyperactive SB100x Transposase. Molecular Therapy. Nucleic Acids. 5: e279. PMID 26784638 DOI: 10.1038/Mtna.2015.54  0.33
2015 Boso G, Somia NV. Characterization of resistance to rhabdovirus and retrovirus infection in a human myeloid cell line. Plos One. 10: e0121455. PMID 25811758 DOI: 10.1371/Journal.Pone.0121455  0.528
2015 Multhaup MM, Podetz-Pedersen KM, Karlen AD, Olson ER, Gunther R, Somia NV, Blazar BR, Cowan MJ, McIvor RS. Role of transgene regulation in ex vivo lentiviral correction of artemis deficiency. Human Gene Therapy. 26: 232-43. PMID 25738323 DOI: 10.1089/Hum.2014.062  0.365
2015 Boso G, Örvell C, Somia NV. The nature of the N-terminal amino acid residue of HIV-1 RNase H is critical for the stability of reverse transcriptase in viral particles. Journal of Virology. 89: 1286-97. PMID 25392207 DOI: 10.1128/Jvi.02312-14  0.336
2014 Podetz-Pedersen KM, Vezys V, Somia NV, Russell SJ, McIvor RS. Cellular immune response against firefly luciferase after sleeping beauty-mediated gene transfer in vivo. Human Gene Therapy. 25: 955-65. PMID 25093708 DOI: 10.1089/Hum.2014.048  0.349
2014 Hackett PB, Somia NV. Delivering the second revolution in site-specific nucleases. Elife. 3: e02904. PMID 24843032 DOI: 10.7554/Elife.02904  0.355
2013 Le H, Vishwanathan N, Kantardjieff A, Doo I, Srienc M, Zheng X, Somia N, Hu WS. Dynamic gene expression for metabolic engineering of mammalian cells in culture. Metabolic Engineering. 20: 212-20. PMID 24055788 DOI: 10.1016/J.Ymben.2013.09.004  0.412
2013 Boso G, Tasaki T, Kwon YT, Somia NV. The N-end rule and retroviral infection: no effect on integrase. Virology Journal. 10: 233. PMID 23849394 DOI: 10.1186/1743-422X-10-233  0.328
2012 Corrigan-Curay J, Cohen-Haguenauer O, O'Reilly M, Ross SR, Fan H, Rosenberg N, Somia N, King N, Friedmann T, Dunbar C, Aiuti A, Naldini L, Baum C, von Kalle C, Kiem HP, et al. Challenges in vector and trial design using retroviral vectors for long-term gene correction in hematopoietic stem cell gene therapy. Molecular Therapy : the Journal of the American Society of Gene Therapy. 20: 1084-94. PMID 22652996 DOI: 10.1038/Mt.2012.93  0.362
2011 Multhaup MM, Gurram S, Podetz-Pedersen KM, Karlen AD, Swanson DL, Somia NV, Hackett PB, Cowan MJ, McIvor RS. Characterization of the human artemis promoter by heterologous gene expression in vitro and in vivo. Dna and Cell Biology. 30: 751-61. PMID 21663454 DOI: 10.1089/Dna.2011.1244  0.448
2011 Cermak T, Doyle EL, Christian M, Wang L, Zhang Y, Schmidt C, Baller JA, Somia NV, Bogdanove AJ, Voytas DF. Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting. Nucleic Acids Research. 39: e82. PMID 21493687 DOI: 10.1093/Nar/Gkr218  0.332
2011 Zu T, Gibbens B, Doty NS, Gomes-Pereira M, Huguet A, Stone MD, Margolis J, Peterson M, Markowski TW, Ingram MA, Nan Z, Forster C, Low WC, Schoser B, Somia NV, et al. Non-ATG-initiated translation directed by microsatellite expansions. Proceedings of the National Academy of Sciences of the United States of America. 108: 260-5. PMID 21173221 DOI: 10.1073/Pnas.1013343108  0.364
2010 Multhaup M, Karlen AD, Swanson DL, Wilber A, Somia NV, Cowan MJ, McIvor RS. Cytotoxicity associated with artemis overexpression after lentiviral vector-mediated gene transfer. Human Gene Therapy. 21: 865-75. PMID 20163250 DOI: 10.1089/Hum.2009.162  0.477
2010 Iizuka YM, Somia NV, Iizuka K. Identification of NK cell receptor ligands using a signaling reporter system. Methods in Molecular Biology (Clifton, N.J.). 612: 285-97. PMID 20033648 DOI: 10.1007/978-1-60761-362-6_19  0.314
2007 Lech P, Somia NV. Isolation and characterization of human cells resistant to retrovirus infection. Retrovirology. 4: 45. PMID 17608937 DOI: 10.1186/1742-4690-4-45  0.518
2007 Gori JL, Podetz-Pedersen K, Swanson D, Karlen AD, Gunther R, Somia NV, McIvor RS. Protection of mice from methotrexate toxicity by ex vivo transduction using lentivirus vectors expressing drug-resistant dihydrofolate reductase. The Journal of Pharmacology and Experimental Therapeutics. 322: 989-97. PMID 17586722 DOI: 10.1124/Jpet.107.123414  0.417
2006 Agarwal S, Harada J, Schreifels J, Lech P, Nikolai B, Yamaguchi T, Chanda SK, Somia NV. Isolation, characterization, and genetic complementation of a cellular mutant resistant to retroviral infection. Proceedings of the National Academy of Sciences of the United States of America. 103: 15933-8. PMID 17043244 DOI: 10.1073/Pnas.0602674103  0.644
2006 Agarwal S, Nikolai B, Yamaguchi T, Lech P, Somia NV. Construction and use of retroviral vectors encoding the toxic gene barnase. Molecular Therapy : the Journal of the American Society of Gene Therapy. 14: 555-63. PMID 16814610 DOI: 10.1016/J.Ymthe.2006.03.025  0.665
2006 Score PR, Belur LR, Frandsen JL, Geurts JL, Guerts JL, Yamaguchi T, Somia NV, Hackett PB, Largaespada DA, McIvor RS. Sleeping Beauty-mediated transposition and long-term expression in vivo: use of the LoxP/Cre recombinase system to distinguish transposition-specific expression. Molecular Therapy : the Journal of the American Society of Gene Therapy. 13: 617-24. PMID 16356773 DOI: 10.1016/J.Ymthe.2005.10.015  0.388
2006 Gori JL, Podetz-Pederson K, Swanson D, Karlin AD, Somia NV, Scott McIvor R. 773. Chemoprotection of Mouse Marrow Transplant Recipients by Ex Vivo Lentiviral Transduction of Murine tyr22 Dihydrofolate Reductase Conferring Resistance to Methotrexate Molecular Therapy. 13: S299. DOI: 10.1016/J.Ymthe.2006.08.859  0.442
2005 McIvor RS, Somia NV, Converse AD. 826. The Risk of Integration: Characterization and Testing of Cell Lines Engineered for the Study of Insertional Gene Activation Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.369  0.449
2004 Somia N. Gene delivery to cells in culture using retroviruses. Methods of Molecular Biology. 246: 491-498. PMID 14970612 DOI: 10.1385/1-59259-650-9:491  0.487
2004 Somia NV. Gene Transfer by Retroviral Vectors Methods of Molecular Biology. 246: 463-490. PMID 14970611 DOI: 10.1385/1-59259-650-9:463  0.413
2004 Converse AD, Somia NV, McIvor RS. 7. The Risk of Integration: Cell Lines for Determining the Frequency and Character of Vector-Mediated Insertional Gene Activation Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.05.088  0.49
2001 Tan S, Somia N, Maher P, Schubert D. Regulation of antioxidant metabolism by translation initiation factor 2alpha. The Journal of Cell Biology. 152: 997-1006. PMID 11238455 DOI: 10.1083/Jcb.152.5.997  0.339
2000 Somia N, Verma IM. Gene therapy: Trials and tribulations Nature Reviews Genetics. 1: 91-99. PMID 11253666 DOI: 10.1038/35038533  0.323
2000 Somia NV, Miyoshi H, Schmitt MJ, Verma IM. Retroviral vector targeting to human immunodeficiency virus type 1-infected cells by receptor pseudotyping. Journal of Virology. 74: 4420-4. PMID 10756057 DOI: 10.1128/Jvi.74.9.4420-4424.2000  0.463
1999 Somia NV, Schmitt MJ, Vetter DE, Van Antwerp D, Heinemann SF, Verma IM. LFG: an anti-apoptotic gene that provides protection from Fas-mediated cell death. Proceedings of the National Academy of Sciences of the United States of America. 96: 12667-72. PMID 10535980 DOI: 10.1073/Pnas.96.22.12667  0.363
1999 Somia NV, Kafri T, Verma IM. Piecing together more efficient gene expression Nature Biotechnology. 17: 224-225. PMID 10096283 DOI: 10.1038/6962  0.39
1997 Verma IM, Somia N. Gene therapy -- promises, problems and prospects. Nature. 389: 239-42. PMID 9305836 DOI: 10.1038/38410  0.374
1995 Somia NV, Zoppé M, Verma IM. Generation of targeted retroviral vectors by using single-chain variable fragment: an approach to in vivo gene delivery. Proceedings of the National Academy of Sciences of the United States of America. 92: 7570-4. PMID 7638232 DOI: 10.1073/Pnas.92.16.7570  0.494
1993 Somia NV, Jessop JK, Melton DW. Phenotypic correction of a human cell line (46BR) with aberrant DNA ligase I activity Mutation Research-Dna Repair. 294: 51-58. PMID 7683758 DOI: 10.1016/0921-8777(93)90057-N  0.329
Show low-probability matches.